Malin investee firms mulling flotations

The main two companies supported by State-backed drug development investment firm Malin are expected to float by the end of next year.

San Diego-based company Poseida, of which Malin owns 33%, has filed for a potential IPO; while UK-based biotech business Immunocore, in which Malin has a 10% stake, has appointed a new chief executive.